Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities ...
The BiaB advantages over traditional methods of RNA manufacturing, include high throughput of high-quality pharmaceutical ...
Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled. A ...
Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such ...
Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...
Quotient Sciences, a leading global drug development and manufacturing accelerator, today announced the installation of Centillion’s™ proprietary Biofoundry-in-a-Box (BiaB™), the first multi-product ...
The COVID-19 pandemic has dramatically transformed our understanding of public health, particularly when it comes to ...
A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...
Most people don’t enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inha ...
Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...
To the growing list of factors required for the export of messenger RNA from nucleus to cytoplasm can now be added Yra1. Yeast Yra1 and its metazoan orthologues bind mRNAs and interact with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback